| High grade serous ovarian carcinomas originate in the fallopian tube SI Labidi-Galy, E Papp, D Hallberg, N Niknafs, V Adleff, M Noe, ... Nature communications 8 (1), 1093, 2017 | 674 | 2017 |
| Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models H Kim, H Xu, E George, D Hallberg, S Kumar, V Jagannathan, ... Nature communications 11 (1), 3726, 2020 | 213 | 2020 |
| GATA3 immunohistochemical expression in salivary gland neoplasms LE Schwartz, S Begum, WH Westra, JA Bishop Head and neck pathology 7, 311-315, 2013 | 127 | 2013 |
| A PET imaging agent for evaluating PARP-1 expression in ovarian cancer M Makvandi, A Pantel, L Schwartz, E Schubert, K Xu, CJ Hsieh, C Hou, ... The Journal of clinical investigation 128 (5), 2116-2126, 2018 | 119 | 2018 |
| Utility of on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspiration specimens AC Griffin, LE Schwartz, ZW Baloch Cytojournal 8, 2011 | 119 | 2011 |
| CDK7 inhibition suppresses castration-resistant prostate cancer through MED1 inactivation R Rasool, R Natesan, Q Deng, S Aras, P Lal, S Sander Effron, ... Cancer discovery 9 (11), 1538-1555, 2019 | 91 | 2019 |
| Innervation of cervical carcinoma is mediated by cancer-derived exosomes CT Lucido, E Wynja, M Madeo, CS Williamson, LE Schwartz, BA Imblum, ... Gynecologic oncology 154 (1), 228-235, 2019 | 58 | 2019 |
| Inherited TP53 variants and risk of prostate cancer KN Maxwell, HH Cheng, J Powers, R Gulati, EM Ledet, C Morrison, A Le, ... European urology 81 (3), 243-250, 2022 | 55 | 2022 |
| Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas GH Lewis, H Wang, AM Bellizzi, AP Klein, FB Askin, LE Schwartz, ... The American journal of surgical pathology 37 (4), 601-605, 2013 | 51 | 2013 |
| Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems H Wachtel, T Hutchens, E Baraban, LE Schwartz, K Montone, Z Baloch, ... The Journal of Clinical Endocrinology & Metabolism 105 (12), e4661-e4670, 2020 | 49 | 2020 |
| Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among … C Parra-Herran, M Taljaard, B Djordjevic, MC Reyes, L Schwartz, ... Modern Pathology 29 (8), 879-892, 2016 | 49 | 2016 |
| Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma S Wu, T Fukumoto, J Lin, T Nacarelli, Y Wang, D Ong, H Liu, ... Nature cancer 2 (2), 189-200, 2021 | 47 | 2021 |
| An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer SB Gitto, H Kim, S Rafail, DK Omran, S Medvedev, Y Kinose, ... Gynecologic Oncology 156 (1), 222-232, 2020 | 41 | 2020 |
| CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models H Xu, E George, Y Kinose, H Kim, JB Shah, JD Peake, B Ferman, ... Cell Reports Medicine 2 (9), 2021 | 38 | 2021 |
| Two types of primary mucinous ovarian tumors can be distinguished based on their origin M Simons, F Simmer, J Bulten, MJ Ligtenberg, H Hollema, S van Vliet, ... Modern Pathology 33 (4), 722-733, 2020 | 31 | 2020 |
| Carcinoma of the uterine cervix involving the genitourinary tract: a potential diagnostic dilemma LE Schwartz, F Khani, JA Bishop, R Vang, JI Epstein The American Journal of Surgical Pathology 40 (1), 27-35, 2016 | 31 | 2016 |
| Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study ML Eich, MCR Pena, L Schwartz, CP Granada, S Rais-Bahrami, ... Human pathology 96, 79-86, 2020 | 25 | 2020 |
| Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients TL Fuchs, F Maclean, J Turchini, AC Vargas, S Bhattarai, A Agaimy, ... Modern Pathology 35 (6), 836-849, 2022 | 23 | 2022 |
| Acquired cystic kidney disease–associated renal cell carcinoma (ACKD-RCC) harbor recurrent mutations in KMT2C and TSC2 genes A Shah, P Lal, E Toorens, MB Palmer, L Schwartz, N Vergara, T Guzzo, ... The American Journal of Surgical Pathology 44 (11), 1479-1486, 2020 | 22 | 2020 |
| CD105 is expressed in ovarian cancer precursor lesions and is required for metastasis to the ovary S Bai, W Zhu, L Coffman, A Vlad, LE Schwartz, E Elishaev, R Drapkin, ... Cancers 11 (11), 1710, 2019 | 22 | 2019 |
